Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	9.32	-26.54	-29.27
Graham Fair Price	inf	0.00	4.79
PEG	inf	0.00	< 0.005
Price/Book	inf	0.00	-0.54
Price/Cash Flow	inf	0.00	90.82
Prices/Earnings	inf	0.00	-0.44
Price/Sales	inf	0.00	1.66
Price/FCF	inf	0.00	90.82
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	2.64	0.28	0.28
Operating Margin	-86.15	-1.34	-0.72
ROA	-1.21	-0.03	-0.03
ROE	0.30	0.22	-26.84
ROIC	-0.05	-0.06	-13.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.06	0.02	250.88
Dividends QOQ	-0.98	-1.00	-1.52
EBIT QOQ	-1.08	-0.06	94.28
EPS QOQ	-1.00	1.00	0.00
FCF QOQ	1.04	1.80	72.89
Revenue QOQ	0.82	-0.43	-47.91
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1708.31	2197.48	28.63
Days Sales Outstanding (DSO)	127.55	650.50	410.00
Inventory Turnover	0.05	0.04	-22.26
Debt/Capitalization	1.21	1.31	8.01
Quick Ratio	0.22	0.32	47.28
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	-1.83	0.00	inf
Cash	3.16	0.00	inf
Capex	< 0.005	0.00	inf
Free Cash Flow	0.01	0.00	inf
Revenue	0.59	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.68	0.69	1.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-26.67	-26.54	0.47
Naive Interpretation	Member

06 - Financial Health · Bad

Rating